This test is most useful if any of these apply to you.
Most vaginal symptoms are diagnosed by guesswork. A doctor sees discharge, makes a clinical call, and prescribes something. About half the time the call is wrong, which is one reason recurrent infections are so common. This panel replaces that guesswork with a molecular read of what is actually living in your vagina.
The picture matters beyond infection treatment. The mix of bacteria in your vagina shapes your risk of contracting a sexually transmitted infection, your chance of carrying a pregnancy to term, your odds of conceiving through assisted reproduction, and your susceptibility to urinary tract infections. A single swab captures all of it.
The panel covers six overlapping clinical questions in one collection. First, the protective bacteria. The Lactobacillus species and the overall lactobacilli load tell you whether your vagina is anchored by the bacteria that produce lactic acid and keep the pH acidic. A vagina dominated by Lactobacillus crispatus is the most stable and protective configuration. A vagina dominated by Lactobacillus iners is more fragile and shifts toward dysbiosis more easily.
Second, bacterial vaginosis. The panel quantifies Gardnerella vaginalis, Atopobium vaginae (also called Fannyhessea vaginae), Prevotella, and Megasphaera, the anaerobic group that crowds out lactobacilli and shifts pH upward. Molecular detection of this group identifies bacterial vaginosis more accurately than the older microscopy-based scoring systems.
Third, sexually transmitted infections. Chlamydia, gonorrhea, trichomoniasis, herpes simplex, and Mycoplasma genitalium are detected directly from the same swab. Fourth, aerobic vaginitis. Group B Streptococcus, E. coli, Staphylococcus aureus, Klebsiella, Proteus, Pseudomonas, and Enterococcus faecalis represent a different pattern of dysbiosis, characterized by inflammation and overgrowth of aerobic bacteria more typical of the gut and skin.
Fifth, yeast. Beyond Candida albicans, the panel detects the non-albicans species (glabrata, krusei, parapsilosis, tropicalis) that respond differently to standard treatment. Sixth, the genital mycoplasmas. Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum are common commensals but can drive inflammation and have been linked to urethritis and pregnancy complications.
No single number in this panel tells the whole story. The combinations are what matters.
| Pattern | What It Suggests |
|---|---|
| High L. crispatus, low Gardnerella, pH under 4.5, no pathogens | Optimal protective state. Stable against infection and supportive of pregnancy. |
| High L. iners, low other lactobacilli, pH near 4.5 | Fragile baseline. Higher risk of shifting into bacterial vaginosis or yeast under stress, antibiotics, or hormonal change. |
| High Gardnerella, Atopobium, Prevotella, or Megasphaera, low total lactobacilli, pH above 4.5 | Bacterial vaginosis pattern. Linked to increased risk of sexually transmitted infections, preterm birth, and pelvic inflammatory disease. |
| High aerobic bacteria (E. coli, GBS, S. aureus), low lactobacilli, pH above 5 | Aerobic vaginitis pattern. Different from bacterial vaginosis and treated differently. |
Detection of Candida is interpreted in the context of symptoms. Candida albicans without symptoms is often normal carriage. Candida glabrata or krusei is clinically meaningful even at lower levels because both species resist standard fluconazole treatment and need a different drug. A positive result for chlamydia, gonorrhea, trichomoniasis, or Mycoplasma genitalium is treated as an infection regardless of symptoms or other findings.
Group B Streptococcus detection has age-specific weight. Outside pregnancy, it is a common colonizer of no immediate clinical consequence. In the third trimester it triggers a recommendation for antibiotics during labor to prevent neonatal sepsis.
A clean result with strong Lactobacillus dominance and no pathogens is the cleanest outcome. Reorder in twelve months unless symptoms emerge, you change sexual partners, you become pregnant, or you take a course of antibiotics. A bacterial vaginosis pattern, even without symptoms, warrants treatment if you are pregnant, trying to conceive, or about to undergo an intrauterine procedure. Untreated bacterial vaginosis raises the risk of HIV acquisition by approximately 60 percent and is associated with elevated risk of gonorrhea, chlamydia, and trichomonas acquisition.
A positive sexually transmitted infection requires treatment plus partner notification and retesting at three months. Aerobic vaginitis is treated with antibiotics chosen for the dominant aerobic organism, not the standard metronidazole used for bacterial vaginosis. Non-albicans Candida requires non-fluconazole treatment, typically boric acid or a newer antifungal.
Recurrent dysbiosis, defined as more than three bacterial vaginosis episodes a year or chronic non-albicans yeast, benefits from serial retesting at six-week intervals during treatment, then at three to six months once stable. Tracking whether Lactobacillus crispatus regrows after treatment predicts whether the next episode is around the corner. If lactobacilli stay low, suppressive therapy or a vaginal Lactobacillus crispatus probiotic becomes a reasonable next step.
Several factors affect the entire panel at once. Recent vaginal intercourse, douching, lubricants, spermicides, or vaginal medications within 48 hours of the swab can shift the bacterial readout. Menstrual blood interferes with detection, so swab at least three days after the end of your period. Recent oral or vaginal antibiotics suppress detection of the organisms they target and temporarily disrupt the lactobacilli population. Estrogen status matters: low estrogen states (postpartum, breastfeeding, menopause) reduce lactobacilli regardless of vaginal health, so the threshold for what counts as normal shifts.
Vaginal Microbiome is best interpreted alongside these tests.